newsfilter
← Latest News
GlobeNewswire·

Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A

NEW HAVEN, Conn., July 29, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. ((TSX.V:BTI, OTCQB:BIOAF) (the "Company" or "Bioasis"), a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics